Details of the Drug
General Information of Drug (ID: DMLLJH4)
| Drug Name |
IC-200214
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
ITI-002A; PDE1 inhibitors (oral, cognitive disorders); PDE1 inhibitors (oral, cognitive disorders), Takeda; Dopamine D1 receptor agonist (oral, cognitive disorders), Intra-Cellular Therapies; ITI-002 series (cognitive disorders), Intra-Cellular Therapies; PDE1 inhibitors (oral, cognitive disorders), Intra-Cellular Therapies
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
